Research
Print page Print page
Switch language
Pathology, Department of - a part of Copenhagen University Hospital
  1. 2016
  2. Ny WHO klassifikation af gliomer inkl. tumormarkører

    Helle Broholm (Lecturer)
    7 Oct 2016

    Activity: Talk or presentationLecture and oral contribution

  3. Effects of bevacizumab combination therapy on transcriptional changes in responding and non-responding recurrent glioblastoma patients

    Helle Broholm (Lecturer)
    19 May 201621 May 2016

    Activity: Talk or presentationLecture and oral contribution

  4. ELMO 3 expression in metastasizing malignant gliomas

    Helle Broholm (Lecturer)
    19 May 201621 May 2016

    Activity: Talk or presentationLecture and oral contribution

  5. Feasibility of Early Postoperative 18F-FET PET/MRI after Surgery for Pediatric Patients with Brain Tumors

    Helle Broholm (Lecturer)
    19 May 201621 May 2016

    Activity: Talk or presentationLecture and oral contribution

  6. KIAA1549-BRAF Fusion-independent RSK Expression in Pilocytic Astrocytoma

    Helle Broholm (Lecturer)
    19 May 201621 May 2016

    Activity: Talk or presentationLecture and oral contribution

  7. Prognostic and Predictive Biomarkers in Recurrent WHO Grade 3 Malignant Glioma Patients Treated with Bevacizumab and Irinotecan

    Helle Broholm (Lecturer)
    19 May 201621 May 2016

    Activity: Talk or presentationLecture and oral contribution

  8. Quantitative and allelic methylation analyses of MGMT in glioblast

    Helle Broholm (Lecturer)
    19 May 201621 May 2016

    Activity: Talk or presentationLecture and oral contribution

  9. VEGF-C contributes to autocrine VEGF Receptor 2 signaling and cellular maintenance in Glioblastoma

    Helle Broholm (Lecturer)
    19 May 201621 May 2016

    Activity: Talk or presentationLecture and oral contribution

ID: 407